Suchergebnisse - "415SHH325A"

PubPharm (956)

1

Therapeutic dilemmas in addressing SARS-CoV-2 infection : Favipiravir versus Remdesivir

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Negru, P. | Radu, A. | Vesa, C. | +8

2

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

enthalten in: Diabetes & metabolic syndrome | 2022

von Singh, A. | Singh, A. | Singh, R. | +1

3

Synthesis of Nucleoside-like Molecules from a Pyrolysis Product of Cellulose and Their Computational Prediction as Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors

enthalten in: International journal of molecular sciences | 2022

von Defant, A. | Dosi, F. | Innocenti, N. | +1

4

Comparing the outcomes of treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) among COVID-19 inpatients

enthalten in: International immunopharmacology | 2021

von Seyfi, S. | Latifi, K. | Amri Male, P. | +3

5

Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models

enthalten in: Scientific reports | 2021

von Wang, Y. | Li, P. | Rajpoot, S. | +7

6

Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9

enthalten in: Scientific reports | 2021

von Lerum, T. | Maltzahn, N. | Aukrust, P. | +74

7

Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model

enthalten in: Journal of microbiology (Seoul, Korea) | 2021

von Kim, E. | Kim, Y. | Jang, S. | +4

8

Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir

enthalten in: Drug research | 2021

von Banerjee, A. | Kanwar, M. | Maiti, S.

9

CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target

enthalten in: SLAS discovery : advancing life sciences R & D | 2021

von Friman, T. | Chernobrovkin, A. | Martinez Molina, D. | +1

10

Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures

enthalten in: Scientific reports | 2021

von Peng, L. | Shen, L. | Xu, J. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[96]